###begin article-title 0
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 40 48 <span type="species:ncbi:9606">Patients</span>
The Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*These authors contributed equally to this work.
###end p 1
###begin p 2
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 896 899 896 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 987 990 987 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 1125 1128 1125 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
###xml 319 324 <span type="species:ncbi:9606">Human</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 1011 1019 <span type="species:ncbi:9606">patients</span>
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders in humans. NF1 is caused by mutations in the NF1 gene which consists of 57 exons and encodes a GTPase activating protein (GAP), neurofibromin. To date, more than 640 different NF1 mutations have been identified and registered in the Human Gene Mutation Database (HGMD). In order to assess the NF1 mutational spectrum in Korean NF1 patients, we screened 23 unrelated Korean NF1 patients for mutations in the coding region and splice sites of the NF1 gene. We have identified 21 distinct NF1 mutations in 22 patients. The mutations included 10 single base substitutions (3 missense and 7 nonsense), 10 splice site mutations, and 1 single base deletion. Eight mutations have been previously identified and thirteen mutations were novel. The mutations are evenly distributed across exon 3 through intron 47 of the NF1 gene and no mutational hot spots were found. This analysis revealed a wide spectrum of NF1 mutations in Korean patients. A genotype-phenotype correlation analysis suggests that there is no clear relationship between specific NF1 mutations and clinical features of the disease.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 739 744 <span type="species:ncbi:9606">human</span>
###xml 836 841 <span type="species:ncbi:9606">Human</span>
Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders, with an estimated incidence of 1 per 3,500 births. NF1 is caused by mutations in the NF1 gene. The NF1 gene maps to 17q11.2, contains 57 exons spanning approximately 280 kb of genomic DNA, and encodes neurofibromin (1, 2). Neurofibromin, which consists of 2,818 amino acids, is widely expressed in many tissues and acts as a Ras GTPase activating protein (GAP) (3). Two functional regions of neurofibromin have been identified and well-defined, a central GAP related domain (GRD) encoded by exons 20-27 (4, 5) and several cAMP-dependent protein kinase recognition sites encoded by exons 11-17 (6). The NF1 gene exhibits one of the highest mutation rates of any human disorder. To date, more than 640 different NF1 mutations have been found and listed in the Human Gene Mutation Database (HGMD). The majority of them lead to a truncated protein product.
###end p 4
###begin p 5
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 789 790 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
NF1 is clinically characterized by cafe-au-lait (CAL) spots, neurofibromas, freckling of the axillary or inguinal region, Lisch nodules, optic nerve glioma, and bone dysplasias (7). These features are present in more than 90% of patients at puberty. Further manifestations such as deeply situated and arbitrarily located neurofibromas, plexiform neurofibromas, macrocephaly, short stature, learning difficulties, scoliosis, and pseudarthrosis, as well as certain malignancies, occur less frequently among patients with NF1 (8). NF1 is notable for its extreme phenotypic variability both within and between families. In addition to multiple allelism of the NF1 locus, the influence of modifying gene(s) and the impact of stochastic events have been suggested as causes of this variability (9, 10). However, evidence supporting these hypotheses has not been reported.
###end p 5
###begin p 6
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
A comprehensive analysis of the mutational spectrum might help to elucidate the molecular basis of different NF1 mutations. In Korea, only three cases of NF1 have been previously reported (11, 12). In order to assess the NF1 mutational spectrum in Korean NF1 patients, we performed phenotypic characterization and mutation analysis in 23 unrelated cases. Here, we report the spectrum of NF1 mutations in Korean NF1 patients, and discuss a genotype-phenotype correlation analysis.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 8
###begin p 9
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Twenty-three NF1 patients of 9 familial and 14 sporadic cases were screened for mutations of the NF1 gene. All subjects were diagnosed to have NF1 based on standard diagnostic criteria (7) at the Genetics Clinic in Ajou University Medical Center between December 2003 and March 2005.
###end p 9
###begin title 10
Phenotypic characterization and mutation analysis
###end title 10
###begin p 11
###xml 131 138 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
Phenotypic characterization of all subjects was done at the Genetics Clinic in Ajou University Medical Center and is summarized in Table 1. Mutation screening was performed in the Medical Genetics Laboratory, Department of Genetics, University of Alabama at Birmingham, U.S.A. Based on the screening data of the NF1 patients, we performed a detailed mutation analysis of the NF1 gene and further analysis of genotype-phenotype correlations.
###end p 11
###begin p 12
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 685 688 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Mutation screening was performed as described previously (13). Briefly, genomic DNA was prepared from blood samples of the patients and total RNA was extracted from lymphocytes isolated from the blood samples and amplified in culture. Microsatellite polymorphism markers were analyzed as a first approach to determine whether 2 copies of the NF1 gene were present. If no heterozygous signal was observed for any of these markers, FISH analysis was performed using PAC clones 22 (926B9; 5' NF1) and 13 (1002G3; 3' NF1) to confirm or rule out a total gene deletion. Thereafter, genomic DNA-PCR and RT-PCR were performed to screen splice site mutations and coding region mutations of the NF1 gene, respectively. Sequencing was performed using dye-primer chemistry on an ABI3100 capillary sequencer (Applied Biosystems, Foster City, CA, U.S.A.).
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
Description of mutations
###end title 14
###begin p 15
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
The patients were analyzed using genomic PCR-directed sequencing, microsatellite polymorphism analysis, FISH analysis, and RT-PCR. Several other methods, including heteroduplex analysis (HA), protein truncation test (PTT), and denaturing high performance liquid chromatography (DHPLC), have been used for analysis of NF1 mutations (13, 14) and are useful for high-throughput detection of mutations. However, we used PCR-directed genomic sequencing as our primary technique to detect mutations because it is very accurate and directly identifies changes in gene sequence.
###end p 15
###begin p 16
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
###xml 641 649 <span type="species:ncbi:9606">patients</span>
###xml 734 742 <span type="species:ncbi:9606">patients</span>
Twenty-three unrelated patients who were clinically diagnosed with NF1 were screened for mutations in the coding region (57 exons) and splice sites of the NF1 gene. Mutations in NF1 were detected in 22 of 23 patients (96%). Mutation analysis revealed a wide spectrum of NF1 mutations in these patients (Table 1). Twenty-one different mutations were identified, which included 10 single base substitutions (3 missense and 7 nonsense), 10 splice site mutations, and 1 single base deletion. Eight mutations (38%) have been previously reported and thirteen mutations (62%) were novel. Only 2 patients shared the same mutation, c.4537C>T, and 20 patients had unique mutations, indicating that no mutational "hot spots" exist in Korean NF1 patients.
###end p 16
###begin p 17
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 82 88 82 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
The mutations were evenly distributed across exon 3 to intron 47 of the NF1 gene (Fig. 1). The previously characterized mutations detected in this study were: IVS8+1G>A in intron 8, c.1381C>T (R461X) in exon 10, c.2446C>T (R816X) in exon 16, c.3827G>A (R1276Q) in exon 22, c.4537C>T (R1513X) in exon 27, c.6709C>T (R2237X) in exon 36, c.6792C>G (Y2264X) in exon 37, and c.6792C>A (Y2264X) in exon 37. The newly identified mutations were: c.236delT in exon 3, c.532G>T (E178X) in exon 4, c.1642-449A>G in intron 10, c.1733T>C (L578P) in exon 12, c.2033_2034insC in intron 13, c.2252-33_-8del26 in intron 14, c.2851-2A>C in intron 16, IVS21+2-3insT in intron 21, c.4269+1_4269+12del12bp in intron 24, 4861G>A and 4862T>G (V1621R) in exon 28, c.5749+4_+7delAGTA in intron 30, c.5750-?_5943+?del in intron 31, and c.61-?_8315-?del in intron 47.
###end p 17
###begin p 18
###xml 241 248 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 295 302 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 273 281 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
The majority of these mutations resulted in a truncated or shortened protein product. Only three missense mutations, L578P, R1276Q, and V1621R, do not affect the size of neurofibromin. Two mutations, c.4537 in exon 27 (patients 14 and 15 in Table 1) and c.6792 in exon 37 (patients 20 and 21 in Table 1) were each found in two patients. Two mutations, R1276Q and R1513X, were detected in the GAP related domain (GRD) which has been suggested to be a "hot spot" for NF1 mutations, given its important functional role in modulating Ras activity (14). Another two mutations, L578P and R816X, were observed in the cAMP-dependent protein kinase recognition sites (6).
###end p 18
###begin title 19
Genotype-phenotype correlation analysis
###end title 19
###begin p 20
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 349 356 349 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
###xml 527 534 <span type="species:ncbi:9606">patient</span>
###xml 771 779 <span type="species:ncbi:9606">patients</span>
Phenotypic characterization revealed that the only clinical feature common to all patients was the CAL spots (Table 1). To identify genotype-phenotype associations, we first analyzed six NF1 patients (5 sporadic cases and 1 familial case) who share an identical phenotype, plexiform neurofibromas. Among them, five patients (5, 7, 14, 15, and 20 in Table 1) possessed mutations which caused a splicing error (c.1642-449A>G and c.2033_2034insC) or mutations which produced a truncated neurofibromin (R1513X and Y2264X), but one patient (16 in Table 1) had a mutation which resulted in an amino acid substitution (V1621R). This result indicates that the effects of different mutations are not always distinguishable at the phenotypic level. Despite distinct genotypes, the patients shared the same phenotype, plexiform neurofibroma, suggesting that there is no obvious correlation between the type of mutation and the severity of the disease.
###end p 20
###begin p 21
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 345 352 <span type="species:ncbi:9606">patient</span>
Similarly, patients 14 and 15 carried the same nonsense mutation (R1513X), but had no clinical features in common, with the exception of the CAL spots. In contrast, patients 20 and 21 who possessed the same truncated neurofibromin by mutation of Y2264X showed distinct clinical features with the occurrence of neurofibromas and scoliosis in one patient, and microcephaly and seizures in the other. Our data suggest that there is no clear relationship between specific NF1 mutations and clinical features.
###end p 21
###begin title 22
DISCUSSION
###end title 22
###begin p 23
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 477 485 <span type="species:ncbi:9606">patients</span>
A survey of previously reported NF1 mutations listed in the HGMD revealed that the most frequent type of mutation is a small deletion and the next most frequent type is nucleotide substitution. However, our data indicate that the most frequent mutation type is nucleotide substitution (11 of 22 cases) and followed by splicing error mutations (10 of 21 cases). Only one deletion mutation was identified in our study, suggesting that the genotypic characteristics of Korean NF1 patients may be distinct from that of other populations.
###end p 23
###begin p 24
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
###xml 786 794 <span type="species:ncbi:9606">patients</span>
Only three cases of NF1 mutation in Koreans have been previously described (11, 12). Park et al. reported two frame shift mutations (a TGGA insertion at codon 1270 of exon 22 and a one base pair deletion at codon 1398 of exon 24) (11) and one nonsense mutation (R1947X) (12). Recently, another 30 Korean cases were reported at the 29th Symposium of the Korean Society of Medical Genetics (2004), by Lee et al., Department of Clinical Genetics, College of Medicine, Yonsei University, Seoul, Korea. A review of the 55 Korean NF1 genotypes available, including the above 30 cases, showed that most Korean NF1 patients bear unique mutations, with the exception of two mutations, c.4537C>T in exon 27 and c.6709C>T in exon 36. These data indicate that the mutational spectrum in Korean NF1 patients is highly variable.
###end p 24
###begin p 25
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 719 720 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 722 723 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 992 994 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1116 1118 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1260 1262 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1398 1405 1394 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 319 324 <span type="species:ncbi:4932">yeast</span>
###xml 1081 1088 <span type="species:ncbi:9606">patient</span>
###xml 1384 1391 <span type="species:ncbi:9606">patient</span>
###xml 1526 1534 <span type="species:ncbi:9606">patients</span>
Two mutations were detected in 3 patients in exons 20-27 which correspond to the GRD of neurofibromin. The GRD is known to be the most important functional domain of the NF1 gene. The predicted GRD in neurofibromin consists of 367 amino acids (1172-1538) and shares homology with GAP family proteins such as p120GAP in yeast and mammals (3). This region of the gene has also been reported as representing a "hot spot" for mutations (15). The crystal structure of the GRD of neurofibromin revealed that three prominent regions in the GRD, the arginine-finger loop, the phenylalanine-leucine-arginine (FLR) region, and the alpha7/variable loop contain structural fingerprints governing the GAP function of neurofibromin (4, 5). The finger loop is crucial for stabilization of the transition state of the GTPase reaction whose function is controlled by residues proximal to the catalytic arginine (R1276). In the previous report, missense mutations at R1276 in the GRD showed severe phenotypes (16). The substitution, R1276P, was found as an apparently spontaneous mutation in an NF1 patient with malignant schwannona (16). The R1276P mutation slightly reduced the binding affinity to Ras, but resulted in an 8000-fold reduction of GAP-stimulated GTP hydrolysis (17), suggesting that the loss of GAP function is critical for the development of neurofibromatosis. In this study, however, patient 12 in Table 1, with the missense mutation R1276Q, showed mild neurofibromas. It may be that the phenotypic variations between the two patients are caused by the difference in the change of the amino acid residues P and Q.
###end p 25
###begin p 26
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 507 517 507 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 507 517 <span type="species:ncbi:7227">Drosophila</span>
A putative second hot spot in a possible functional domain upstream of GRD, comprising exons 11-17, has been described (6, 16). The region is rich in cysteine and serine, with three cysteine pairs suggestive of ATP binding sites, as well as three potential cAMP-dependent protein kinase recognition sites. Two mutations, L578P and R816X, have been observed in two of the cAMP-dependent protein kinase recognition sites (6). Further evidence for cAMP signaling being perturbed in NF1 comes from mutations in Drosophila neurofibromin that have been shown to inhibit the cAMP-dependent protein kinase signaling pathway (6, 18).
###end p 26
###begin p 27
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
Many NF1 patients have been genotyped, but little evidence of genotype-phenotype correlation has been observed (19). This may indicate that the phenotypic differences resulting from NF1 allelic heterogeneity are generally small in comparison to other sources of variability. It is also possible, however, that important NF1 genotype-phenotype correlations exist but have not been recognized because of the complexity of the NF1 phenotype and the heterogeneity of pathogenic NF1 mutations (13, 15, 17).
###end p 27
###begin p 28
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 928 931 928 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 400 407 <span type="species:ncbi:9606">patient</span>
###xml 639 646 <span type="species:ncbi:9606">patient</span>
###xml 804 812 <span type="species:ncbi:9606">patients</span>
###xml 1035 1043 <span type="species:ncbi:9606">patients</span>
###xml 1191 1199 <span type="species:ncbi:9606">patients</span>
In this study, Korean NF1 patients showed a wide range of phenotypic variations. We found that patients exhibited different disease phenotypes, even though they carried an identical NF1 mutant allele. Two patients (14, 15) shared the same mutation, R1513X, but their clinical features were substantially different. Although they shared the clinical features of CAL spots and plexiform neurofibromas, patient 15 also showed several other NF1 clinical features including subcutaneous plexiform neurofibromas, freckling, Lish nodules, and subcutaneous neurofibromas (Table 1). R1513X is one of the most prevalent NF1 gene mutations (20). One patient with R1513X mutation was characterized by the typical clinical features of CAL spots, axillary freckling, and nodular neurofibromas (14). In contrast, other patients with the R1513X mutation had malignant myeloid disorders (21). These data indicate that the R1513X mutation in the NF1 gene is associated with malignant myeloid disorders as well as NF1. Comparison of phenotypes among the patients with R1513X mutation, in previously reported studies and in this study, reveals that there is no correlation between genotype and phenotype in NF1 patients.
###end p 28
###begin p 29
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1168 1169 1168 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 484 491 <span type="species:ncbi:9606">patient</span>
###xml 536 543 <span type="species:ncbi:9606">patient</span>
###xml 556 563 <span type="species:ncbi:9606">patient</span>
###xml 759 766 <span type="species:ncbi:9606">patient</span>
###xml 1007 1015 <span type="species:ncbi:9606">patients</span>
###xml 1024 1032 <span type="species:ncbi:9606">patients</span>
###xml 1089 1097 <span type="species:ncbi:9606">patients</span>
Other common mutations, c.6792C>G and c.6792C>A, caused an alternative splicing event which skipped exon 37 and produced a neurofibromin protein lacking 34 amino acid residues (22). These mutations were found in patients 20 and 21, respectively. Even though these mutations result in the same effect at the protein level, Y2264X, their phenotypes were distinguished by the presence of plexiform neurofibromas, cutaneous neurofibromas, subcutaneous neurofibromas, and scoliosis in the patient 20, versus microcephaly and seizures in the patient 21. One NF1 patient with a Y2264X mutation was reported (23) to have symptomatic optic glioma and multiple clinical features that do not fulfill the NIH criteria (7) for the clinical diagnosis of NF1, while another patient with the same mutation was reported to have the typical clinical features of NF1, CAL spots, axillary freckling, and cutaneous neurofibromas. Analysis of the genotype-phenotype correlation by comparison of clinical features among the above patients and the patients in this study suggests that phenotypic variation in NF1 patients is not correlated with the type of mutations, as reported previously (8-10).
###end p 29
###begin p 30
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 600 608 <span type="species:ncbi:9606">patients</span>
In conclusion, the location and type of mutation within the NF1 gene and its putative effect at the protein level do not indicate a relationship to any specific clinical features of NF1, suggesting that unlinked modifying gene(s) may be involved in the development of particular clinical features of NF1 and that some of the clinical variability that characterizes NF1 may result from association of more than one genetic factor. Recently two candidate modifiers for NF1, GDNF and TLF, have been reported (24, 25). However, there has been no clear evidence to explain the phenotypic variations among patients with an identical mutation.
###end p 30
###begin p 31
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
A larger number of NF1 cases may be required to identify potential genotype-phenotype correlations in Korean patients with NF1. A functional analysis of NF1 gene mutations in specific regions, such as the GRD, may clarify the mechanisms of pathogenesis associated with NF1. This study will contribute to a better understanding the genotypic and phenotypic characteristics of Korean NF1 patients.
###end p 31
###begin p 32
###xml 74 121 74 121 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health &amp; Welfare, Republic of Korea</funding-source>
###xml 123 130 123 130 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A050234</award-id>
This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (A050234).
###end p 32
###begin article-title 33
Genomic organization of the neurofibromatosis 1 gene (NF1)
###end article-title 33
###begin article-title 34
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product
###end article-title 34
###begin article-title 35
The neurofibromatosis type 1 gene encodes a protein related to GAP
###end article-title 35
###begin article-title 36
Structural analysis of the GAP-related domain from neurofibromin and its implications
###end article-title 36
###begin article-title 37
Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP
###end article-title 37
###begin article-title 38
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain
###end article-title 38
###begin article-title 39
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
###end article-title 39
###begin article-title 40
Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1)
###end article-title 40
###begin article-title 41
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes
###end article-title 41
###begin article-title 42
Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers
###end article-title 42
###begin article-title 43
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Identification of two novel frame shift mutations of the NF1 gene in Korean patients with neurofibromatosis type 1
###end article-title 43
###begin article-title 44
###xml 98 105 <span type="species:ncbi:9606">patient</span>
A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient
###end article-title 44
###begin article-title 45
Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
###end article-title 45
###begin article-title 46
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1
###end article-title 46
###begin article-title 47
Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene
###end article-title 47
###begin article-title 48
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1
###end article-title 48
###begin article-title 49
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain
###end article-title 49
###begin article-title 50
###xml 68 78 <span type="species:ncbi:7227">Drosophila</span>
A neurofibromatosis-1-regulated pathway is required for learning in Drosophila
###end article-title 50
###begin article-title 51
Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)
###end article-title 51
###begin article-title 52
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients
###end article-title 52
###begin article-title 53
###xml 66 74 <span type="species:ncbi:9606">children</span>
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
###end article-title 53
###begin article-title 54
Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene
###end article-title 54
###begin article-title 55
###xml 33 40 <span type="species:ncbi:9606">patient</span>
Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1)
###end article-title 55
###begin article-title 56
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype
###end article-title 56
###begin article-title 57
TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP
###end article-title 57
###begin article-title 58
Characterization and Significance of nine novel mutation in exon 16 of the neurofibromatosis type I (NF1) gene
###end article-title 58
###begin article-title 59
Two recurrent nonsense mutations and a 4bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene
###end article-title 59
###begin p 60
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Location of the NF1 gene mutations detected in 22 unrelated Korean NF1 patients. The cAMP protein kinase recognition sites (cAMP/PK) spanning exons 11-17 and the GAP related domain (GRD) region spanning exons 20-27 are highlighted.
###end p 60
###begin p 61
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Summary of clinical features and genotypic characteristics of 23 Korean patients with NF1
###end p 61
###begin p 62
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S/F</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CALs</italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CNf</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCNf</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNf</italic>
###xml 152 154 152 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LN</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 199 201 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PA</italic>
Legend: S/F, Sporadic/Familial; CALs, Cafe-au-Lait Spots; CNf, Cutaneous Neurofibromas; SCNf, Subcutaneous Neurofibromas; PNf, Plexiform Neurofibromas; LN, Lisch Nodules; F, Freckling; S, Scoliosis; PA, Pseudarthrosis.
###end p 62
###begin p 63
Nucleotide numbering is based on the NF1 cDNA sequence (GenBank accession No. M82814) and genomic DNA sequence (GenBank accession No. AY796305).
###end p 63

